Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Ultomiris recommended for approval in the EU by CHMP for children and adolescents with paroxysmal nocturnal haemoglobinuria
-
Vaxzevria is highly effective after one dose against severe disease or hospitalisation caused by Beta and Delta variants of concern
-
Acquisition of Alexion completed
-
Imfinzi approved in China for the treatment of extensive-stage small cell lung cancer
-
Status on FDA Advisory Committee vote on roxadustat in anaemia of chronic kidney disease
-
AstraZeneca receives final regulatory clearance for the proposed acquisition of Alexion from the UK’s Competition and Markets Authority
-
Tezepelumab regulatory submission accepted and granted FDA Priority Review in the US for the treatment of patients with asthma
-
AstraZeneca receives clearance from the European Commission for the proposed acquisition of Alexion
-
Vaxzevria induced immunity for at least one year following a single dose and strong immune responses following either a late second dose or a third dose
-
AstraZeneca Appoints Dr. Susan Galbraith as Executive Vice President, Oncology Research & Development
Latest articles and press releases
All of our latest press releases and articles are available to explore
